Effects of empagliflozin in women and men with heart failure and preserved ejection fraction
Background: Women and men with heart failure (HF) and preserved ejection fraction may differ in their clinical characteristics and their response to therapy. The aim of this study was to evaluate the influence of sex on the effects of empagliflozin in patients with HF and preserved ejection fraction...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
13 Sep 2022
|
| In: |
Circulation
Year: 2022, Jahrgang: 146, Heft: 14, Pages: 1046-1055 |
| ISSN: | 1524-4539 |
| DOI: | 10.1161/CIRCULATIONAHA.122.059755 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1161/CIRCULATIONAHA.122.059755 Verlag, kostenfrei, Volltext: http://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.059755 
|
| Verfasserangaben: | Javed Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, João Pedro Ferreira, Martina Brueckmann, Edimar Bocchi, Michael Böhm, Vijay K. Chopra, Nadia Giannetti, Tomoko Iwata, James L. Januzzi, Sanjay Kaul, Ileana L. Piña, Piotr Ponikowski, Ursula Rauch-Kröhnert, Sanjiv J. Shah, Michele Senni, Mikhail Sumin, Subodh Verma, Jian Zhang, Stuart J. Pocock, Faiez Zannad, Milton Packer, Stefan D. Anker |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1854032631 | ||
| 003 | DE-627 | ||
| 005 | 20240307085556.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230801s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIRCULATIONAHA.122.059755 |2 doi | |
| 035 | |a (DE-627)1854032631 | ||
| 035 | |a (DE-599)KXP1854032631 | ||
| 035 | |a (OCoLC)1425217118 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Butler, Javed |e VerfasserIn |0 (DE-588)1136309578 |0 (DE-627)892627859 |0 (DE-576)490416683 |4 aut | |
| 245 | 1 | 0 | |a Effects of empagliflozin in women and men with heart failure and preserved ejection fraction |c Javed Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, João Pedro Ferreira, Martina Brueckmann, Edimar Bocchi, Michael Böhm, Vijay K. Chopra, Nadia Giannetti, Tomoko Iwata, James L. Januzzi, Sanjay Kaul, Ileana L. Piña, Piotr Ponikowski, Ursula Rauch-Kröhnert, Sanjiv J. Shah, Michele Senni, Mikhail Sumin, Subodh Verma, Jian Zhang, Stuart J. Pocock, Faiez Zannad, Milton Packer, Stefan D. Anker |
| 264 | 1 | |c 13 Sep 2022 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 01.08.2023 | ||
| 520 | |a Background: Women and men with heart failure (HF) and preserved ejection fraction may differ in their clinical characteristics and their response to therapy. The aim of this study was to evaluate the influence of sex on the effects of empagliflozin in patients with HF and preserved ejection fraction enrolled in the EMPEROR-Preserved trial (Empagliflozin Outcome Trial in Patients With Chronic Heart Failure With Preserved Ejection Fraction). Methods: The effects of empagliflozin on the primary outcome of cardiovascular death or hospitalization for HF and on secondary outcomes (including total HF hospitalization, cardiovascular and all-cause mortality, and Kansas City Cardiomyopathy Questionnaire scores) were compared in women and men in the overall cohort and in subgroups defined by left ventricular ejection fraction (41%-49%, 50%-59%, and ≥60%). The effects of empagliflozin on physiological measures, including changes in systolic blood pressure, uric acid, hemoglobin, body weight, and natriuretic peptide levels, were also assessed. Results: Of the 5988 patients randomized, 2676 (44.7%) were women. In the placebo arm, women tended to have lower risk for adverse outcomes, including a lower risk of all-cause mortality (hazard ratio, 0.69 [95% CI, 0.56, 0.84]). Compared with placebo, empagliflozin reduced the risk of cardiovascular death or hospitalization for HF to a similar degree in both sexes (hazard ratio, 0.81 [95% CI, 0.69, 0.96] for men; and hazard ratio, 0.75 [95% CI, 0.61, 0.92] for women; Pinteraction=0.54). Sex did not modify the relationship between empagliflozin and outcomes across ejection fraction groups. Similar results were seen for secondary outcomes and physiological measures. Compared with placebo, empagliflozin improved the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score to a similar extent in both sexes (1.38 for men versus 1.63 for women at 52 weeks; Pinteraction=0.77); the results were similar for Kansas City Cardiomyopathy Questionnaire overall summary score and total summary score. Conclusions: Empagliflozin produced similar benefits on outcomes and health status in women and men with HF and preserved ejection fraction. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03057951. | ||
| 650 | 4 | |a empagliflozin | |
| 650 | 4 | |a health status | |
| 650 | 4 | |a heart failure | |
| 650 | 4 | |a hospitalization | |
| 650 | 4 | |a men | |
| 650 | 4 | |a women | |
| 700 | 1 | |a Filippatos, Gerasimos |e VerfasserIn |4 aut | |
| 700 | 1 | |a Siddiqi, Tariq Jamal |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ferreira, João Pedro |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brückmann, Martina |d 1970- |e VerfasserIn |0 (DE-588)121145069 |0 (DE-627)705257290 |0 (DE-576)292557736 |4 aut | |
| 700 | 1 | |a Bocchi, Edimar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Böhm, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chopra, Vijay K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Giannetti, Nadia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Iwata, Tomoko |e VerfasserIn |4 aut | |
| 700 | 1 | |a Januzzi, James L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kaul, Sanjay |e VerfasserIn |4 aut | |
| 700 | 1 | |a Piña, Ileana L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ponikowski, Piotr |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rauch-Kröhnert, Ursula |e VerfasserIn |4 aut | |
| 700 | 1 | |a Shah, Sanjiv J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Senni, Michele |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sumin, Mikhail |e VerfasserIn |4 aut | |
| 700 | 1 | |a Verma, Subodh |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zhang, Jian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pocock, Stuart J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zannad, Faiez |e VerfasserIn |4 aut | |
| 700 | 1 | |a Packer, Milton |e VerfasserIn |4 aut | |
| 700 | 1 | |a Anker, Stefan D. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation |d Philadelphia, Pa. : Lippincott, Williams & Wilkins, 1950 |g 146(2022), 14 vom: Okt., Seite 1046-1055 |h Online-Ressource |w (DE-627)265784670 |w (DE-600)1466401-X |w (DE-576)074891189 |x 1524-4539 |7 nnas |a Effects of empagliflozin in women and men with heart failure and preserved ejection fraction |
| 773 | 1 | 8 | |g volume:146 |g year:2022 |g number:14 |g month:10 |g pages:1046-1055 |g extent:10 |a Effects of empagliflozin in women and men with heart failure and preserved ejection fraction |
| 856 | 4 | 0 | |u https://doi.org/10.1161/CIRCULATIONAHA.122.059755 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.059755 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230801 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 121145069 |a Brückmann, Martina |m 121145069:Brückmann, Martina |d 60000 |e 60000PB121145069 |k 0/60000/ |p 5 | ||
| 999 | |a KXP-PPN1854032631 |e 436178115X | ||
| BIB | |a Y | ||
| SER | |a newspaper | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"13 Sep 2022"}],"relHost":[{"pubHistory":["1.1950 -"],"disp":"Effects of empagliflozin in women and men with heart failure and preserved ejection fractionCirculation","origin":[{"dateIssuedKey":"1950","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]","publisher":"Lippincott, Williams & Wilkins ; Ovid","dateIssuedDisp":"1950-"}],"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"American Heart Association"}],"part":{"text":"146(2022), 14 vom: Okt., Seite 1046-1055","issue":"14","extent":"10","year":"2022","pages":"1046-1055","volume":"146"},"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["265784670"],"zdb":["1466401-X"],"issn":["1524-4539"]},"language":["eng"],"recId":"265784670","title":[{"title_sort":"Circulation","title":"Circulation","subtitle":"an official journal of the American Heart Association"}],"note":["Gesehen am 10.10.2025"],"type":{"media":"Online-Ressource","bibl":"newspaper"}}],"name":{"displayForm":["Javed Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, João Pedro Ferreira, Martina Brueckmann, Edimar Bocchi, Michael Böhm, Vijay K. Chopra, Nadia Giannetti, Tomoko Iwata, James L. Januzzi, Sanjay Kaul, Ileana L. Piña, Piotr Ponikowski, Ursula Rauch-Kröhnert, Sanjiv J. Shah, Michele Senni, Mikhail Sumin, Subodh Verma, Jian Zhang, Stuart J. Pocock, Faiez Zannad, Milton Packer, Stefan D. Anker"]},"physDesc":[{"extent":"10 S."}],"language":["eng"],"id":{"eki":["1854032631"],"doi":["10.1161/CIRCULATIONAHA.122.059755"]},"recId":"1854032631","title":[{"title":"Effects of empagliflozin in women and men with heart failure and preserved ejection fraction","title_sort":"Effects of empagliflozin in women and men with heart failure and preserved ejection fraction"}],"person":[{"display":"Butler, Javed","family":"Butler","roleDisplay":"VerfasserIn","given":"Javed","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Filippatos","display":"Filippatos, Gerasimos","role":"aut","given":"Gerasimos"},{"display":"Siddiqi, Tariq Jamal","family":"Siddiqi","roleDisplay":"VerfasserIn","given":"Tariq Jamal","role":"aut"},{"family":"Ferreira","display":"Ferreira, João Pedro","roleDisplay":"VerfasserIn","role":"aut","given":"João Pedro"},{"display":"Brückmann, Martina","family":"Brückmann","roleDisplay":"VerfasserIn","given":"Martina","role":"aut"},{"role":"aut","given":"Edimar","roleDisplay":"VerfasserIn","display":"Bocchi, Edimar","family":"Bocchi"},{"display":"Böhm, Michael","family":"Böhm","roleDisplay":"VerfasserIn","role":"aut","given":"Michael"},{"display":"Chopra, Vijay K.","family":"Chopra","roleDisplay":"VerfasserIn","given":"Vijay K.","role":"aut"},{"given":"Nadia","role":"aut","roleDisplay":"VerfasserIn","family":"Giannetti","display":"Giannetti, Nadia"},{"roleDisplay":"VerfasserIn","display":"Iwata, Tomoko","family":"Iwata","role":"aut","given":"Tomoko"},{"roleDisplay":"VerfasserIn","family":"Januzzi","display":"Januzzi, James L.","role":"aut","given":"James L."},{"role":"aut","given":"Sanjay","display":"Kaul, Sanjay","family":"Kaul","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Piña, Ileana L.","family":"Piña","role":"aut","given":"Ileana L."},{"given":"Piotr","role":"aut","roleDisplay":"VerfasserIn","family":"Ponikowski","display":"Ponikowski, Piotr"},{"roleDisplay":"VerfasserIn","display":"Rauch-Kröhnert, Ursula","family":"Rauch-Kröhnert","role":"aut","given":"Ursula"},{"given":"Sanjiv J.","role":"aut","roleDisplay":"VerfasserIn","display":"Shah, Sanjiv J.","family":"Shah"},{"display":"Senni, Michele","family":"Senni","roleDisplay":"VerfasserIn","role":"aut","given":"Michele"},{"display":"Sumin, Mikhail","family":"Sumin","roleDisplay":"VerfasserIn","role":"aut","given":"Mikhail"},{"given":"Subodh","role":"aut","roleDisplay":"VerfasserIn","display":"Verma, Subodh","family":"Verma"},{"given":"Jian","role":"aut","roleDisplay":"VerfasserIn","family":"Zhang","display":"Zhang, Jian"},{"role":"aut","given":"Stuart J.","display":"Pocock, Stuart J.","family":"Pocock","roleDisplay":"VerfasserIn"},{"given":"Faiez","role":"aut","family":"Zannad","display":"Zannad, Faiez","roleDisplay":"VerfasserIn"},{"role":"aut","given":"Milton","roleDisplay":"VerfasserIn","family":"Packer","display":"Packer, Milton"},{"display":"Anker, Stefan D.","family":"Anker","roleDisplay":"VerfasserIn","given":"Stefan D.","role":"aut"}],"note":["Gesehen am 01.08.2023"],"type":{"media":"Online-Ressource","bibl":"article-newspaper"}} | ||
| SRT | |a BUTLERJAVEEFFECTSOFE1320 | ||